C-EMR: Endoscopic Mucosal Resection With Circumferential Incision for Colorectal Neoplasms

Sponsor
State Scientific Centre of Coloproctology, Russian Federation (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT05690490
Collaborator
(none)
90
1
2
36
2.5

Study Details

Study Description

Brief Summary

This is a prospective randomized trial to improve the results of treatment of patients with colorectal neoplasms.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Endoscopic mucosal resection with circumferential incision
  • Procedure: Endoscopic submucosal dissection
N/A

Detailed Description

Generally, endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD) are the methods of choice for the removal of benign and early malignant neoplasms of the colon. However, there are certain difficulties in terms of the EMR technique - this is an increase in the frequency of fragmentation with a lesion size of more than 20 mm, which in turn increases the risk of recurrence; with regard to ESD technique, this is a long procedure time; high incidence of complications; significant time required for teaching the technique; technical difficulties. In this regard, it is worth paying attention to the method of "endoscopic mucosal resection with circumferential mucosal incision" (C-EMR). This method deserves interest due to the fact that it allows more often to perform en-block resections in comparison with the classical method of endoscopic mucosal resection (EMR - endoscopic mucosal resection); technically easier to do; takes a short procedure time.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
90 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
prospective, single-center, randomized, non inferiorityprospective, single-center, randomized, non inferiority
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Treament for Colorectal Neoplasms by Metod Endoscopic Mucosal Resection With Circumferential Mucosal Incision
Actual Study Start Date :
Nov 27, 2020
Anticipated Primary Completion Date :
Sep 27, 2023
Anticipated Study Completion Date :
Nov 27, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: endoscopic mucosal resection with circumferential incision

The endoscope will be passed into the intestine to the site of the tumor. Then, using an endoscopic needle, a solution will be injected into the submucosa to remove the neoplasm. Using an endoscopic knife (insulated tip knife, Olympus or Water Jet, Erbe), a circular incision will be made around the lesion. Then there will be a one-stage electro excision of the neoplasm using an endoscopic loop.

Procedure: Endoscopic mucosal resection with circumferential incision
The endoscope will be passed into the intestine to the site of the tumor. Using an endoscopic needle, the solution will be injected into the submucosa to create a pillow. Then, using an endoscopic knife (insulated tip knife, Olympus or Water Jet, Erbe), a circular incision will be made around the lesion with an offset of 2-5 mm. Then there will be a one-stage electro excision of the neoplasm using an endoscopic loop.

Active Comparator: endoscopic submucosal dissection

The endoscope will be passed into the intestine to the site of the tumor. Then, using an endoscopic needle, a solution will be injected into the submucosa to remove the neoplasm. Using an endoscopic knife (Insulated Tip Knife, Olympus or Water Jet, Erbe), the lesion will be resected through the submucosal plane using the eb-block principle, after which the patient will be monitored.

Procedure: Endoscopic submucosal dissection
The endoscope will be passed into the intestine to the site of the tumor. Using an endoscopic needle, the solution will be injected into the submucosa to create a pillow. Then, using an endoscopic knife (insulated tip knife, Olympus or Water Jet, Erbe), a circular incision is made around the lesion. Then dissection will be performed in the submucosal layer.

Outcome Measures

Primary Outcome Measures

  1. R0 resection rate [14 day]

Secondary Outcome Measures

  1. En-block resesction rate [14 day]

  2. conversion rate [1 day]

  3. intervention time [1 day]

  4. intra- and postoperative complications rate [30 day]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • patients with benign colon neoplasms without signs of deep invasion (I, II, IIIL and IV type according to Kudo, I and II type according to Sano)

  • the size of the neoplasm is from 20 mm to 30 mm

  • patient for treatment

Exclusion Criteria:
  • unsatisfactory tumor lifting

  • refusal of the patient from research at any stage of treatment

Contacts and Locations

Locations

Site City State Country Postal Code
1 Elmira Moscow Russian Federation

Sponsors and Collaborators

  • State Scientific Centre of Coloproctology, Russian Federation

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
State Scientific Centre of Coloproctology, Russian Federation
ClinicalTrials.gov Identifier:
NCT05690490
Other Study ID Numbers:
  • 26/20
First Posted:
Jan 19, 2023
Last Update Posted:
Jan 19, 2023
Last Verified:
Jan 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by State Scientific Centre of Coloproctology, Russian Federation
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 19, 2023